Found: 82
Select item for more details and to access through your institution.
Immune-related [<sup>18</sup>F]FDG PET findings in patients undergoing checkpoint inhibitors treatment: correlation with clinical adverse events and prognostic implications.
- Published in:
- Cancer Imaging, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s40644-024-00774-9
- By:
- Publication type:
- Article
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-a) treatment of human cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2005, v. 54, n. 1, p. 1, doi. 10.1007/s00262-004-0549-1
- By:
- Publication type:
- Article
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?
- Published in:
- Non-Coding RNA, 2020, v. 6, n. 3, p. 1, doi. 10.3390/ncrna6030026
- By:
- Publication type:
- Article
Aberrant glycosylation as biomarker for cancer: focus on CD43.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/742831
- By:
- Publication type:
- Article
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/217365
- By:
- Publication type:
- Article
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17579, doi. 10.1038/srep17579
- By:
- Publication type:
- Article
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 2, p. 189, doi. 10.3390/cells11020189
- By:
- Publication type:
- Article
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 9, p. 1964, doi. 10.3390/cells9091964
- By:
- Publication type:
- Article
MENTAL ADJUSTMENT TO CANCER: THE ROLE OF ANXIOUS AND DEPRESSIVE SYMPTOMS UNDER TREATMENT.
- Published in:
- International Journal of Psychiatry in Medicine, 2013, v. 46, n. 4, p. 375, doi. 10.2190/PM.46.4.d
- By:
- Publication type:
- Article
The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro-apoptotic activity of interferon-α through the inhibition of multiple survival pathways.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 10, p. 2317, doi. 10.1002/ijc.22964
- By:
- Publication type:
- Article
Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
- Published in:
- International Journal of Cancer, 2004, v. 112, n. 5, p. 754, doi. 10.1002/ijc.20472
- By:
- Publication type:
- Article
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia.
- Published in:
- BMC Medical Genomics, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1755-8794-6-27
- By:
- Publication type:
- Article
The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives.
- Published in:
- Experimental Hematology & Oncology, 2023, v. 12, n. 1, p. 1, doi. 10.1186/s40164-022-00368-w
- By:
- Publication type:
- Article
Therapeutic activation of G protein-coupled estrogen receptor 1 in Waldenström Macroglobulinemia.
- Published in:
- Experimental Hematology & Oncology, 2022, v. 11, n. 1, p. 1, doi. 10.1186/s40164-022-00305-x
- By:
- Publication type:
- Article
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.579445
- By:
- Publication type:
- Article
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0767-6
- By:
- Publication type:
- Article
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2197, doi. 10.3390/ijms25042197
- By:
- Publication type:
- Article
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810222
- By:
- Publication type:
- Article
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11639, doi. 10.3390/ijms222111639
- By:
- Publication type:
- Article
DMET-Analyzer: automatic analysis of Affymetrix DMET Data.
- Published in:
- BMC Bioinformatics, 2012, v. 13, n. 1, p. 258, doi. 10.1186/1471-2105-13-258
- By:
- Publication type:
- Article
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 8, p. 1, doi. 10.1002/ardp.202300134
- By:
- Publication type:
- Article
Automatic summarisation and annotation of microarray data.
- Published in:
- Soft Computing - A Fusion of Foundations, Methodologies & Applications, 2011, v. 15, n. 8, p. 1505, doi. 10.1007/s00500-010-0600-4
- By:
- Publication type:
- Article
The farnesyl transferase inhibitor R115777 (Zarnestra<sup>®</sup>) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa<sup>®</sup>) and Pamidronate.
- Published in:
- Oncogene, 2004, v. 23, n. 41, p. 6900, doi. 10.1038/sj.onc.1207814
- By:
- Publication type:
- Article
OAB-009: Genome-wide CRISPR interference screen identifies RNA Regulator of Lipogenesis (RROL) as a leading LncRNA dependency in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S6, doi. 10.1016/S2152-2650(21)02083-8
- By:
- Publication type:
- Article
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e107, doi. 10.1016/j.clml.2019.09.176
- By:
- Publication type:
- Article
FlowCT: A semi-automated workflow for deconvolution of immunophenotypic data and objective reporting on large datasets.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e94, doi. 10.1016/j.clml.2019.09.153
- By:
- Publication type:
- Article
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
- Published in:
- Journal of Ovarian Research, 2016, v. 9, p. 1, doi. 10.1186/s13048-016-0238-7
- By:
- Publication type:
- Article
A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?
- Published in:
- Journal of Ovarian Research, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1757-2215-6-10
- By:
- Publication type:
- Article
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02633-0
- By:
- Publication type:
- Article
Radiomics predicts survival of patients with advanced non-small cell lung cancer undergoing PD-1 blockade using Nivolumab.
- Published in:
- Oncology Letters, 2020, v. 19, n. 2, p. 1559, doi. 10.3892/ol.2019.11220
- By:
- Publication type:
- Article
Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00348
- By:
- Publication type:
- Article
Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?
- Published in:
- Journal of Drug Delivery, 2013, p. 1, doi. 10.1155/2013/905091
- By:
- Publication type:
- Article
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01622-x
- By:
- Publication type:
- Article
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01468-8
- By:
- Publication type:
- Article
A peroxisome proliferator-activated receptor gamma ( PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 4, p. 529, doi. 10.1111/j.1365-2141.2011.08622.x
- By:
- Publication type:
- Article
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 4, p. 520, doi. 10.1111/j.1365-2141.2008.07387.x
- By:
- Publication type:
- Article
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications.
- Published in:
- British Journal of Haematology, 2008, v. 141, n. 5, p. 598, doi. 10.1111/j.1365-2141.2008.07044.x
- By:
- Publication type:
- Article
Gene expression analysis of B-lymphoma cells resistant and sensitive to bortezomib.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 2, p. 145, doi. 10.1111/j.1365-2141.2006.06132.x
- By:
- Publication type:
- Article
In vivo and in vitro cytotoxicity of R-etodolac with dexamethasone in glucocorticoid-resistant multiple myeloma cells.
- Published in:
- British Journal of Haematology, 2006, v. 134, n. 1, p. 37, doi. 10.1111/j.1365-2141.2006.06122.x
- By:
- Publication type:
- Article
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-59485-3
- By:
- Publication type:
- Article
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1145986
- By:
- Publication type:
- Article
<i>In Vivo</i> Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0090005
- By:
- Publication type:
- Article
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089659
- By:
- Publication type:
- Article
UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 555, doi. 10.1111/bjh.19183
- By:
- Publication type:
- Article
Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 2359, doi. 10.2147/IJN.S58362
- By:
- Publication type:
- Article
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0714-9
- By:
- Publication type:
- Article
The role of brain radiotherapy for EGFR- and ALK-positive non-small-cell lung cancer with brain metastases: a review.
- Published in:
- La Radiologia Medica, 2023, v. 128, n. 3, p. 316, doi. 10.1007/s11547-023-01602-z
- By:
- Publication type:
- Article
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report.
- Published in:
- Therapeutic Advances in Chronic Disease, 2022, p. 1, doi. 10.1177/20406223211063024
- By:
- Publication type:
- Article